EQS-Adhoc

    129 Aufrufe 129 0 Kommentare 0 Kommentare

    STRABAG SE: Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE

    Für Sie zusammengefasst
    • Dr. Hans Peter Haselsteiner reappointed as Authorized Rep.
    • Continuity ensured after Klemens Haselsteiner's loss.
    • Succession planning for CEO position has commenced.

    EQS-Ad-hoc: STRABAG SE / Key word(s): Personnel
    STRABAG SE: Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE

    27-Jan-2025 / 14:40 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
    The issuer is solely responsible for the content of this announcement.


    Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE
    • Continuity at STRABAG SE ensured following the tragic loss of Klemens Haselsteiner
    • Management Board to continue Strategy 2030: People. Planet. Progress.
    • Succession planning for position of CEO has begun

    The Management Board of STRABAG SE, with the approval of the Supervisory Board, has granted Dr. Hans Peter Haselsteiner general power of attorney with effect from today. In keeping with Klemens Haselsteiner’s vision, the Management Board will continue the far-reaching transformation process initiated under the title “Work On Progress”.

    During his tenure as CEO, Dr. Hans Peter Haselsteiner grew the company into an international group. He then continued to serve the Management Board in an advisory capacity as Authorised Representative until his son Klemens Haselsteiner took office on 1 January 2020.

    The foundation Haselsteiner Familien-Privatstiftung currently holds 30.7% of the shares of STRABAG SE.

    The Supervisory Board has already begun deliberating on a successor for the position of CEO.

    Until this position is filled, the remaining members of the Management Board will assume the responsibilities previously held by Klemens Haselsteiner. This will ensure the seamless continuation of these business areas and of the Management Board’s Strategy 2030: People. Planet. Progress.


    End of Inside Information

    27-Jan-2025 CET/CEST News transmitted by EQS Group. www.eqs.com


    Language: English
    Company: STRABAG SE
    Donau-City-Straße 9
    1220 Vienna
    Austria
    Phone: +43 1 22422 – 1089
    Fax: +43 1 22422 - 1177
    E-mail: investor.relations@strabag.com
    Internet: www.strabag.com
    ISIN: AT000000STR1
    Listed: Vienna Stock Exchange (Official Market)
    EQS News ID: 2075389

     
    End of Announcement EQS News Service

    2075389  27-Jan-2025 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=2075389&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc STRABAG SE: Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE EQS-Ad-hoc: STRABAG SE / Key word(s): Personnel STRABAG SE: Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE 27-Jan-2025 / 14:40 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the …